333 SOUTH GRAND AVENUE, LOS ANGELES, CA, UNITED STATES, 90071
国家
美国
上市日期
2024-12-16
财年截止
十二月
流通股数
2458万
CIK
0002029769
官方网址
--
Oaktree Acquisition Corp. III Life Sciences Unit (OACCU) 是一家专业收购公司,专注于与生命科学领域的创新企业合并。凭借经验丰富的管理团队的专业能力,OACCU 旨在通过投资制药、生物技术和医疗技术领域的高潜力公司,应对关键的医疗保健挑战。凭借对充满活力的生命科学格局的战略关注,OACCU 致力于通过促进创新、改善患者预后和完善医疗管理解决方案来创造股东价值。
财务指标
营业收入
2026-06-30
$0
2026-03-31
$0
2025-12-31
$0
2025-09-30
$0
营业支出
2026-06-30
$26.19万
2026-03-31
$45.65万
2025-12-31
$25.54万
2025-09-30
$22.55万
净利润
2026-06-30
$160.46万
2026-03-31
$139.41万
2025-12-31
$178.89万
2025-09-30
$196.67万
净利润率
2026-06-30
--
2026-03-31
--
2025-12-31
--
2025-09-30
--
每股收益
2026-06-30
$0.06
2026-03-31
$0.05
2025-12-31
$0.07
2025-09-30
$0.08
息税折旧摊销前利润
2026-06-30
-$26.19万
2026-03-31
-$45.65万
2025-12-31
-$25.54万
2025-09-30
-$22.55万
有效税率
2026-06-30
--
2026-03-31
--
2025-12-31
--
2025-09-30
--
项目
2026-06-30
2026-03-31
2025-12-31
2025-09-30
营业收入
$0
$0
$0
$0
营业支出
$26.19万
$45.65万
$25.54万
$22.55万
净利润
$160.46万
$139.41万
$178.89万
$196.67万
净利润率
--
--
--
--
每股收益
$0.06
$0.05
$0.07
$0.08
息税折旧摊销前利润
-$26.19万
-$45.65万
-$25.54万
-$22.55万
有效税率
--
--
--
--
常见问题
OACCU is a Nasdaq-listed ticker representing units of Oaktree Acquisition Corp. III, a special purpose acquisition company (SPAC). SPAC units typically consist of one Class A ordinary share and a fraction of a warrant. As a blank-check entity, OACCU was formed to pursue a merger, capital stock exchange, asset acquisition, or similar business combination with an unidentified target company. Investors should review the latest prospectus and SEC filings for specific unit composition and trust details.
OACCU's price is influenced by several drivers: progress in identifying and completing a business combination, redemption activity among unit holders, changes in the trust account's per-unit value, and broader SPAC market sentiment. Interest rates and general equity market conditions also matter, since higher rates can reduce the appeal of pre-deal SPAC units. Because OACCU has no operating business, news about a potential target, deal terms, or shareholder approvals tends to have an outsized impact on trading.
Traditional operating metrics like P/E or EV/EBITDA are generally not meaningful for OACCU because it is a blank-check company with no revenue or earnings. Instead, focus on the per-unit trust value, any accrued interest, and the relationship between the market price and the trust balance. The trust account details and unit composition are available in OACCU's SEC filings. For current figures, refer to the latest OACCU data displayed on this page.
To buy OACCU, you typically need a brokerage account that supports Nasdaq-listed securities. OACCU units trade under their own ticker, separate from any underlying Class A shares or warrants that may later trade independently. Place an order through your broker during regular market hours using the OACCU symbol. Confirm with your brokerage whether unit separation has occurred, since that can change what you are actually purchasing.
Because OACCU is a SPAC, useful metrics differ from those of an operating company. The trust account balance per unit, total funds held in trust, accrued interest, and the deadline to complete a business combination are key. Also monitor redemption levels, sponsor promote structure, and any extension or amendment terms disclosed in OACCU's filings. Once a target is announced, review the target's own revenue, margins, and cash flow projections in the merger documentation.
Watch for OACCU announcements about a potential or definitive business combination, shareholder meeting dates, redemption deadlines, and any extensions to the completion window. SEC filings, including 8-Ks and proxy statements, provide the most reliable updates. Track the trust account value and the spread between OACCU's market price and its trust value for signals about deal expectations. Current price and other live figures are shown on this page.